iRhythm Holdings (IRTC) Restructuring Costs (2022 - 2023)
iRhythm Holdings' (IRTC) quarterly Restructuring Costs came in at $11.1 million in Q4 2023, down 58.37% on a QoQ basis from $26.6 million in Q1 2022.
iRhythm Holdings (IRTC) Restructuring Costs (2022 - 2023) Analysis & Trends
iRhythm Holdings (IRTC) has 2 years of Restructuring Costs data on file, last reported at $11.1 million in Q4 2023.
- On a quarterly basis, Restructuring Costs changed N/A year-over-year to $11.1 million in Q4 2023; TTM through Dec 2023 was $11.1 million, a 58.37% decrease from a year earlier, with the FY2024 full-year figure at $641000.0, down 94.21% from the prior year.
- Restructuring Costs for Q4 2023 stood at $11.1 million, down from $26.6 million in the prior quarter.
- Over the last five years, Restructuring Costs for IRTC reached as high as $26.6 million in Q1 2022 and fell as low as $11.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | iRhythm Holdings | 3.50 Bn | 2.95 Bn | 141.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 11.08 Mn |
| Mar 31, 2022 | 26.61 Mn |